Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001606 · ClinicalTrials.gov registry record
Genetic Analysis of Human Hereditary Hearing Impairment
A clinical trial, sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD).
- Terminated
- Registry status
- 404
- Enrollment target
NCT00001606: Clinical Trial study, sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD).
NCT00001606 is a clinical trial that was terminated before completion, run by National Institute on Deafness and Other Communication Disorders (NIDCD). The registered enrollment target is 404 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001606 was terminated before completion, sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD).
- TERMINATED
- Registry status
- 404 participants
- Enrollment target
Study Summary
This studied is designed to discover the genes that cause hearing impairment. More precisely, this study aims to map and clone genes that are important for the development and maintenance of the anatomy and physiology related to hearing (auditory system). The study will begin by finding large families who have members with hearing impairment. Once families are found, members with and without hearing impairment will be evaluated by an audiologist and a clinician (doctor). An audiologist, is a person trained in evaluating, habilitating, and rehabilitating people with disorders of hearing function. The clinician's responsibility is to examine the patients and check for other signs and symptoms related to hearing. Finding the gene for hearing impairment requires: 1. \<TAB\>DNA samples of hearing impaired family members, taken from standard blood samples. 2. \<TAB\>DNA samples of members of the family without hearing impairment, taken from standard blood samples. 3. \<TAB\>Results of hearing tests conducted by the audiologist for all participants. Once all members of the family are evaluated researchers can create a pedigree. A pedigree is like a family tree that charts members of a family with a genetic disorder, like hearing impairment. Pedigrees are used to determine the mode of inheritance of the gene responsible for a particular condition. Finally, researcher intend on using all the information gathered as well as methods for genetic analysis to map out the location of the gene. Patients participating in this study will not directly benefit from its research, but scientific understanding achieved may help researchers better understand the auditory system and someday prevent deafness.\<TAB\>...
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 404 participants |
| Start Date | 1997-09-08 |
| Est. Completion | 2015-04-07 |
Why NCT00001606 stopped before completion
NCT00001606 is an observational study that tracks outcomes without assigning an intervention. The registered 404 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00001606 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001606 about?
NCT00001606 is a clinical study titled "Genetic Analysis of Human Hereditary Hearing Impairment". This studied is designed to discover the genes that cause hearing impairment. More precisely, this study aims to map and clone genes that are important for the development and maintenance of the anatomy and physiology related to hearing (auditory system). The study will begin by finding large famil...
What is the current status of trial NCT00001606?
This trial is currently terminated. The enrollment target is 404 participants. The study started on 1997-09-08. Estimated completion is 2015-04-07.
Who is sponsoring clinical trial NCT00001606?
This trial is sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD), which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05049057 · 404 participants · Phase 2
Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
- NCT05611242 · 404 participants · Phase 3
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
- NCT06072612 · 404 participants · Phase 3
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- NCT05576350 · 405 participants · NA
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI